{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:45:25Z","timestamp":1790819125762,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["ECO202006011710"],"award-info":[{"award-number":["ECO202006011710"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FDT202304016494"],"award-info":[{"award-number":["FDT202304016494"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FDT202304016494"],"award-info":[{"award-number":["FDT202304016494"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["ECO202006011710"],"award-info":[{"award-number":["ECO202006011710"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004795","name":"Institut Universitaire de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-024-00551-3","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T12:28:58Z","timestamp":1726662538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adaptation mechanisms of Clostridioides difficile to auranofin and its impact on human gut microbiota"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3951-1495","authenticated-orcid":false,"given":"Cyril","family":"Anjou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9milie","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Bredon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Le Bris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria Alonso","family":"Salgueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5940-2990","authenticated-orcid":false,"given":"L\u00e9o C.","family":"Caulat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Barbut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-0523","authenticated-orcid":false,"given":"Claire","family":"Morvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rolhion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Martin-Verstraete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"551_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.20","volume":"2","author":"WK Smits","year":"2016","unstructured":"Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H. & Kuijper, E. J. Clostridium difficile infection. Nat. Rev. Dis. Prim. 2, 16020 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"551_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fmicb.2018.00646","volume":"9","author":"H Sch\u00e4ffler","year":"2018","unstructured":"Sch\u00e4ffler, H. & Breitr\u00fcck, A. Clostridium difficile\u2014from colonization to infection. Front. Microbiol. 9, 646 (2018).","journal-title":"Front. Microbiol."},{"key":"551_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4114","volume":"5","author":"CM Theriot","year":"2014","unstructured":"Theriot, C. M. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 5, 3114 (2014).","journal-title":"Nat. Commun."},{"key":"551_CR4","doi-asserted-by":"crossref","unstructured":"Couturier, J., Davies, K. & Barbut, F. Ribotypes and new virulent strains across Europe. in Updates on Clostridioides difficile in Europe (Advances in Experimental Medicine and Biology, Vol. 1435) (eds Mastrantonio, P. & Rupnik, M.) 151\u2013168 (Springer International Publishing, 2024).","DOI":"10.1007\/978-3-031-42108-2_8"},{"key":"551_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4161\/19490976.2014.969632","volume":"5","author":"MM Awad","year":"2014","unstructured":"Awad, M. M., Johanesen, P. A., Carter, G. P., Rose, E. & Lyras, D. Clostridium difficile virulence factors: insights into an anaerobic spore-forming pathogen. Gut Microbes 5, 579\u2013593 (2014).","journal-title":"Gut Microbes"},{"key":"551_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-micro-090816-093458","volume":"71","author":"K Aktories","year":"2017","unstructured":"Aktories, K., Schwan, C. & Jank, T. Clostridium difficile toxin biology. Annu. Rev. Microbiol. 71, 281\u2013307 (2017).","journal-title":"Annu. Rev. Microbiol."},{"key":"551_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nature09397","volume":"467","author":"SA Kuehne","year":"2010","unstructured":"Kuehne, S. A. et al. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467, 711\u2013713 (2010).","journal-title":"Nature"},{"key":"551_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrmicro.2016.108","volume":"14","author":"MC Abt","year":"2016","unstructured":"Abt, M. C., McKenney, P. T. & Pamer, E. G. Clostridium difficile colitis: pathogenesis and host defence. Nat. Rev. Microbiol. 14, 609\u2013620 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"551_CR9","doi-asserted-by":"crossref","unstructured":"Naz, F. & Petri, W. A. Host immunity and immunization strategies for Clostridioides difficile infection. Clin. Microbiol. Rev. 36, e00157-22 (2023).","DOI":"10.1128\/cmr.00157-22"},{"key":"551_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.anaerobe.2018.03.001","volume":"53","author":"K Aktories","year":"2018","unstructured":"Aktories, K., Papatheodorou, P. & Schwan, C. Binary Clostridium difficile toxin (CDT)\u2014a virulence factor disturbing the cytoskeleton. Anaerobe 53, 21\u201329 (2018).","journal-title":"Anaerobe"},{"key":"551_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1099\/jmm.0.45804-0","volume":"54","author":"F Barbut","year":"2005","unstructured":"Barbut, F. et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J. Med. Microbiol 54, 181\u2013185 (2005).","journal-title":"J. Med. Microbiol"},{"key":"551_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/1469-0691.12046","volume":"18","author":"CP Kelly","year":"2012","unstructured":"Kelly, C. P. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin. Microbiol. Infect. 18, 21\u201327 (2012).","journal-title":"Clin. Microbiol. Infect."},{"key":"551_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5009\/gnl18071","volume":"13","author":"JH Song","year":"2019","unstructured":"Song, J. H. & Kim, Y. S. Recurrent Clostridium difficile infection: risk factors, treatment, and prevention. Gut Liver 13, 16\u201324 (2019).","journal-title":"Gut Liver"},{"key":"551_CR14","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.3390\/microorganisms9091922","volume":"9","author":"J Meza-Torres","year":"2021","unstructured":"Meza-Torres, J., Auria, E., Dupuy, B. & Tremblay, Y. D. N. Wolf in sheep\u2019s clothing: Clostridioides difficile biofilm as a reservoir for recurrent infections. Microorganisms 9, 1922 (2021).","journal-title":"Microorganisms"},{"key":"551_CR15","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3390\/microorganisms11102525","volume":"11","author":"D Rubio-Mendoza","year":"2023","unstructured":"Rubio-Mendoza, D., Mart\u00ednez-Mel\u00e9ndez, A., Maldonado-Garza, H. J., C\u00f3rdova-Fletes, C. & Garza-Gonz\u00e1lez, E. Review of the impact of biofilm formation on recurrent Clostridioides difficile infection. Microorganisms 11, 2525 (2023).","journal-title":"Microorganisms"},{"key":"551_CR16","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","volume":"27","author":"J van Prehn","year":"2021","unstructured":"van Prehn, J. et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin. Microbiol. Infect. Dis. 27, S1\u2013S21 (2021).","journal-title":"Clin. Microbiol. Infect. Dis."},{"key":"551_CR17","unstructured":"European Centre for Disease prevention and Control. Clostridioides (Clostridium) difficile infections\u2014Annual Epidemiological Report for 2016\u20132017. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/clostridiodes-difficile-infections-annual-epidemiological-report-2016-2017 (2022)."},{"key":"551_CR18","unstructured":"Centers for Disease Control and Prevention (U.S.). Antibiotic Resistance Threats in the United States, 2019 (Centers for Disease Control and Prevention (U.S.), 2019)."},{"key":"551_CR19","doi-asserted-by":"crossref","unstructured":"Di Bella, S. et al. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. Clin. Microbiol. Rev. 37, e00135-23 (2024).","DOI":"10.1128\/cmr.00135-23"},{"key":"551_CR20","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.cmi.2021.04.004","volume":"27","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection. Clin. Microbiol. Infect. Dis. 27, 1448\u20131454 (2021).","journal-title":"Clin. Microbiol. Infect. Dis."},{"key":"551_CR21","doi-asserted-by":"crossref","unstructured":"Wynn, A. B., Beyer, G., Richards, M. & Ennis, L. A. Procedure, screening, and cost of fecal microbiota transplantation. Cureus 15, e35116 (2023).","DOI":"10.7759\/cureus.35116"},{"key":"551_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"TJ Louie","year":"2011","unstructured":"Louie, T. J. et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N. Engl. J. Med. 364, 422\u2013431 (2011).","journal-title":"N. Engl. J. Med."},{"key":"551_CR23","doi-asserted-by":"crossref","unstructured":"Minkoff, N. Z. et al. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile). Cochrane Database Syst. Rev. 4, CD013871 (2023).","DOI":"10.1002\/14651858.CD013871.pub2"},{"key":"551_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/jac\/dky375","volume":"74","author":"J Schwanbeck","year":"2019","unstructured":"Schwanbeck, J. et al. Characterization of a clinical Clostridioides difficile isolate with markedly reduced fidaxomicin susceptibility and a V1143D mutation in rpoB. J. Antimicrob. Chemother. 74, 6\u201310 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"551_CR25","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1093\/jac\/dkad194","volume":"78","author":"H Marchandin","year":"2023","unstructured":"Marchandin, H. et al. In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile. J. Antimicrob. Chemother. 78, 1992\u20131999 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"551_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa1602615","volume":"376","author":"MH Wilcox","year":"2017","unstructured":"Wilcox, M. H. et al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N. Engl. J. Med. 376, 305\u2013317 (2017).","journal-title":"N. Engl. J. Med."},{"key":"551_CR27","doi-asserted-by":"crossref","unstructured":"Suarez-Almazor, M. E., Spooner, C., Belseck, E. & Shea, B. Auranofin versus placebo in rheumatoid arthritis. Cochrane Database Syst. Rev. 2000, CD002048 (2000).","DOI":"10.1002\/14651858.CD002048"},{"key":"551_CR28","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.1504022112","volume":"112","author":"MB Harbut","year":"2015","unstructured":"Harbut, M. B. et al. Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proc. Natl. Acad. Sci. USA 112, 4453\u20134458 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"551_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijantimicag.2018.09.018","volume":"53","author":"A AbdelKhalek","year":"2019","unstructured":"AbdelKhalek, A., Abutaleb, N. S., Mohammad, H. & Seleem, M. N. Antibacterial and antivirulence activities of auranofin against Clostridium difficile. Int. J. Antimicrob. Agents 53, 54\u201362 (2019).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"551_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnw148","volume":"363","author":"JP Owings","year":"2016","unstructured":"Owings, J. P. et al. Auranofin and N-heterocyclic carbene gold-analogs are potent inhibitors of the bacteria Helicobacter pylori. FEMS Microbiol. Lett. 363, fnw148 (2016).","journal-title":"FEMS Microbiol. Lett."},{"key":"551_CR31","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.drudis.2022.02.010","volume":"27","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics. Drug Discov. Today 27, 1961\u20131973 (2022).","journal-title":"Drug Discov. Today"},{"key":"551_CR32","first-page":"409","volume":"75","author":"ML Hutton","year":"2019","unstructured":"Hutton, M. L. et al. Repurposing auranofin as a Clostridioides difficile therapeutic. J. Antimicrob. Chemother. 75, 409\u2013417 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"551_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00775-009-0466-z","volume":"14","author":"S Jackson-Rosario","year":"2009","unstructured":"Jackson-Rosario, S. et al. Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au-Se adduct. J. Biol. Inorg. Chem. 14, 507\u2013519 (2009).","journal-title":"J. Biol. Inorg. Chem."},{"key":"551_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64882-9","volume":"10","author":"NS Abutaleb","year":"2020","unstructured":"Abutaleb, N. S. & Seleem, M. N. Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection. Sci. Rep. 10, 7701 (2020).","journal-title":"Sci. Rep."},{"key":"551_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86595-3","volume":"11","author":"NS Abutaleb","year":"2021","unstructured":"Abutaleb, N. S. & Seleem, M. N. In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection. Sci. Rep. 11, 7093 (2021).","journal-title":"Sci. Rep."},{"key":"551_CR36","doi-asserted-by":"crossref","unstructured":"Ruth, M. M. et al. Auranofin activity exposes thioredoxin reductase as a viable drug target in Mycobacterium abscessus. Antimicrob. Agents Chemother. 63, e00449-19 (2019).","DOI":"10.1128\/AAC.00449-19"},{"key":"551_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62696-3","volume":"10","author":"A Elkashif","year":"2020","unstructured":"Elkashif, A. & Seleem, M. N. Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae. Sci. Rep. 10, 5602 (2020).","journal-title":"Sci. Rep."},{"key":"551_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26674-0","volume":"8","author":"A AbdelKhalek","year":"2018","unstructured":"AbdelKhalek, A., Abutaleb, N. S., Elmagarmid, K. A. & Seleem, M. N. Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci. Sci. Rep. 8, 8353 (2018).","journal-title":"Sci. Rep."},{"key":"551_CR39","doi-asserted-by":"publisher","first-page":"e1012001","DOI":"10.1371\/journal.ppat.1012001","volume":"20","author":"C Anjou","year":"2024","unstructured":"Anjou, C. et al. The multiplicity of thioredoxin systems meets the specific lifestyles of Clostridia. PLoS Pathog. 20, e1012001 (2024).","journal-title":"PLoS Pathog."},{"key":"551_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15236-5","volume":"7","author":"KN McAllister","year":"2017","unstructured":"McAllister, K. N., Bouillaut, L., Kahn, J. N., Self, W. T. & Sorg, J. A. Using CRISPR-Cas9-mediated genome editing to generate C. difficile mutants defective in selenoproteins synthesis. Sci. Rep. 7, 14672 (2017).","journal-title":"Sci. Rep."},{"key":"551_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF00871641","volume":"66","author":"JR Andreesen","year":"1994","unstructured":"Andreesen, J. R. Glycine metabolism in anaerobes. Antonie Van. Leeuwenhoek 66, 223\u2013237 (1994).","journal-title":"Antonie Van. Leeuwenhoek"},{"key":"551_CR42","doi-asserted-by":"publisher","first-page":"e00229-22","DOI":"10.1128\/jb.00229-22","volume":"0","author":"MA Johnstone","year":"2022","unstructured":"Johnstone, M. A. & Self, W. T. d-Proline reductase underlies proline-dependent growth of Clostridioides difficile. J. Bacteriol. 0, e00229-22 (2022).","journal-title":"J. Bacteriol."},{"key":"551_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2022.102600","volume":"76","author":"A Pavao","year":"2022","unstructured":"Pavao, A. et al. Reconsidering the in vivo functions of Clostridial Stickland amino acid fermentations. Anaerobe 76, 102600 (2022).","journal-title":"Anaerobe"},{"key":"551_CR44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.cbpa.2004.08.002","volume":"8","author":"JR Andreesen","year":"2004","unstructured":"Andreesen, J. R. Glycine reductase mechanism. Curr. Opin. Chem. Biol. 8, 454\u2013461 (2004).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"551_CR45","doi-asserted-by":"publisher","first-page":"12967","DOI":"10.1073\/pnas.1812781115","volume":"115","author":"RM Buey","year":"2018","unstructured":"Buey, R. M. et al. Ferredoxin-linked flavoenzyme defines a family of pyridine nucleotide-independent thioredoxin reductases. Proc. Natl. Acad. Sci. USA 115, 12967\u201312972 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"551_CR46","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1128\/JCM.01121-14","volume":"52","author":"CD Doern","year":"2014","unstructured":"Doern, C. D. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J. Clin. Microbiol. 52, 4124\u20134128 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"551_CR47","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1111\/1462-2920.14642","volume":"21","author":"N Kint","year":"2019","unstructured":"Kint, N. et al. The \u03c3B signalling activation pathway in the enteropathogen Clostridioides difficile. Environ. Microbiol. 21, 2852\u20132870 (2019).","journal-title":"Environ. Microbiol."},{"key":"551_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-020-00151-9","volume":"6","author":"CJ Norsigian","year":"2020","unstructured":"Norsigian, C. J. et al. Systems biology analysis of the Clostridioides difficile core-genome contextualizes microenvironmental evolutionary pressures leading to genotypic and phenotypic divergence. Npj Syst. Biol. Appl. 6, 31 (2020).","journal-title":"Npj Syst. Biol. Appl."},{"key":"551_CR49","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/1040841X.2022.2054307","volume":"49","author":"H Chandra","year":"2023","unstructured":"Chandra, H., Sorg, J. A., Hassett, D. J. & Sun, X. Regulatory transcription factors of Clostridioides difficile pathogenesis with a focus on toxin regulation. Crit. Rev. Microbiol. 49, 334\u2013349 (2023).","journal-title":"Crit. Rev. Microbiol."},{"key":"551_CR50","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1111\/1462-2920.13696","volume":"19","author":"N Kint","year":"2017","unstructured":"Kint, N. et al. The alternative sigma factor \u03c3B plays a crucial role in adaptive strategies of Clostridium difficile during gut infection: role of \u03c3B in stress adaptation in C. difficile. Environ. Microbiol. 19, 1933\u20131958 (2017).","journal-title":"Environ. Microbiol."},{"key":"551_CR51","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3389\/fmicb.2020.01939","volume":"11","author":"O Soutourina","year":"2020","unstructured":"Soutourina, O. et al. Genome-wide transcription start site mapping and promoter assignments to a sigma factor in the human enteropathogen Clostridioides difficile. Front. Microbiol. 11, 1939 (2020).","journal-title":"Front. Microbiol."},{"key":"551_CR52","doi-asserted-by":"crossref","unstructured":"Cheng, J. K. J. et al. Regulatory role of anti-sigma factor RsbW in Clostridioides difficile stress response, persistence, and infection. J. Bacteriol. 205, e00466-22 (2023).","DOI":"10.1128\/jb.00466-22"},{"key":"551_CR53","doi-asserted-by":"crossref","unstructured":"Rizvi, A. et al. Glycine fermentation by C. difficile promotes virulence and spore formation, and is induced by host cathelicidin. Infect. Immun. 91, e00319-23 (2023).","DOI":"10.1128\/iai.00319-23"},{"key":"551_CR54","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha, S. R. et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe 27, 659\u2013670.e5 (2020).","journal-title":"Cell Host Microbe"},{"key":"551_CR55","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.aam9949","volume":"357","author":"MX Byndloss","year":"2017","unstructured":"Byndloss, M. X. et al. Microbiota-activated PPAR-\u03b3-signaling inhibits dysbiotic Enterobacteriaceae expansion. Science 357, 570\u2013575 (2017).","journal-title":"Science"},{"key":"551_CR56","doi-asserted-by":"crossref","unstructured":"Kint, N. et al. How the anaerobic enteropathogen Clostridioides difficile tolerates low O2 tensions. mBio 11, e01559-20 (2020).","DOI":"10.1128\/mBio.02678-20"},{"key":"551_CR57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.mib.2021.11.009","volume":"65","author":"N Kint","year":"2022","unstructured":"Kint, N., Morvan, C. & Martin-Verstraete, I. Oxygen response and tolerance mechanisms in Clostridioides difficile. Curr. Opin. Microbiol. 65, 175\u2013182 (2022).","journal-title":"Curr. Opin. Microbiol."},{"key":"551_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12087-8","volume":"10","author":"L Li","year":"2019","unstructured":"Li, L. et al. An in vitro model maintaining taxon-specific functional activities of the gut microbiome. Nat. Commun. 10, 4146 (2019).","journal-title":"Nat. Commun."},{"key":"551_CR59","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1080\/19490976.2020.1755413","volume":"11","author":"L Li","year":"2020","unstructured":"Li, L. et al. Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes. Gut Microbes 11, 1348\u20131361 (2020).","journal-title":"Gut Microbes"},{"key":"551_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2035658","volume":"14","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Evaluating live microbiota biobanking using an ex vivo microbiome assay and metaproteomics. Gut Microbes 14, 2035658 (2022).","journal-title":"Gut Microbes"},{"key":"551_CR61","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/cts.12761","volume":"13","author":"J Sunwoo","year":"2020","unstructured":"Sunwoo, J. et al. Impact of vancomycin\u2010induced changes in the intestinal microbiota on the pharmacokinetics of simvastatin. Clin. Transl. Sci. 13, 752\u2013760 (2020).","journal-title":"Clin. Transl. Sci."},{"key":"551_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-019-0087-4","volume":"5","author":"T Dubois","year":"2019","unstructured":"Dubois, T. et al. A microbiota-generated bile salt induces biofilm formation in Clostridium difficile. NPJ Biofilms Microbiomes 5, 14 (2019).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"551_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-363","volume":"10","author":"M Gonzales","year":"2010","unstructured":"Gonzales, M. et al. Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection. BMC Infect. Dis. 10, 363 (2010).","journal-title":"BMC Infect. Dis."},{"key":"551_CR64","doi-asserted-by":"publisher","unstructured":"Capparelli, E. V., Bricker-Ford, R., Rogers, M. J., McKerrow, J. H. & Reed, S. L. Phase I clinical trial results of auranofin, a novel antiparasitic agent. Antimicrob. Agents Chemother. 61 https:\/\/doi.org\/10.1128\/aac.01947-16 (2016).","DOI":"10.1128\/aac.01947-16"},{"key":"551_CR65","doi-asserted-by":"crossref","unstructured":"Cole, J. A. Anaerobic bacterial response to nitrosative stress. Adv. Microb. Physiol. 72, 193\u2013237 (2018).","DOI":"10.1016\/bs.ampbs.2018.01.001"},{"key":"551_CR66","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.freeradbiomed.2014.11.013","volume":"80","author":"LB Poole","year":"2015","unstructured":"Poole, L. B. The basics of thiols and cysteines in redox biology and chemistry. Free Radic. Biol. Med. 80, 148\u2013157 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"551_CR67","doi-asserted-by":"crossref","unstructured":"Marreddy, R. K. R., Olaitan, A. O., May, J. N., Dong, M. & Hurdle J. G. Ebselen not only inhibits Clostridioides difficile toxins but displays redox-associated cellular killing. Microbiol. Spectr. 9, e00448-21 (2021).","DOI":"10.1128\/Spectrum.00448-21"},{"key":"551_CR68","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1096\/fj.12-223305","volume":"27","author":"J Lu","year":"2013","unstructured":"Lu, J. et al. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione. FASEB J. 27, 1394\u20131403 (2013).","journal-title":"FASEB J."},{"key":"551_CR69","doi-asserted-by":"crossref","unstructured":"McAllister, K. N., Martinez Aguirre, A. & Sorg, J. A. The selenophosphate synthetase gene, selD, is important for Clostridioides difficile physiology. J. Bacteriol. 203, e00008-21 (2021).","DOI":"10.1128\/JB.00008-21"},{"key":"551_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36796-9","volume":"13","author":"MA Johnstone","year":"2023","unstructured":"Johnstone, M. A., Holman, M. A. & Self, W. T. Inhibition of selenoprotein synthesis is not the mechanism by which auranofin inhibits growth of Clostridioides difficile. Sci. Rep. 13, 14733 (2023).","journal-title":"Sci. Rep."},{"key":"551_CR71","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jgar.2019.11.020","volume":"22","author":"H Chen","year":"2020","unstructured":"Chen, H., Liu, Y., Liu, Z. & Li, J. Mutation in trxB leads to auranofin resistance in Staphylococcus aureus. J. Glob. Antimicrob. Resist. 22, 135\u2013136 (2020).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"551_CR72","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/JB.186.2.326-334.2004","volume":"186","author":"O Uziel","year":"2004","unstructured":"Uziel, O., Borovok, I., Schreiber, R., Cohen, G. & Aharonowitz, Y. Transcriptional regulation of the Staphylococcus aureus thioredoxin and thioredoxin reductase genes in response to oxygen and disulfide stress. J. Bacteriol. 186, 326\u2013334 (2004).","journal-title":"J. Bacteriol."},{"key":"551_CR73","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/pro.3819","volume":"29","author":"PJ Stogios","year":"2020","unstructured":"Stogios, P. J. & Savchenko, A. Molecular mechanisms of vancomycin resistance. Protein Sci. 29, 654\u2013669 (2020).","journal-title":"Protein Sci."},{"key":"551_CR74","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41559-020-01299-7","volume":"4","author":"N Taib","year":"2020","unstructured":"Taib, N. et al. Genome-wide analysis of the Firmicutes illuminates the diderm\/monoderm transition. Nat. Ecol. Evol. 4, 1661\u20131672 (2020).","journal-title":"Nat. Ecol. Evol."},{"key":"551_CR75","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/microorganisms8122024","volume":"8","author":"I Maus","year":"2020","unstructured":"Maus, I. et al. The role of petrimonas mucosa ING2-E5AT in mesophilic biogas reactor systems as deduced from multiomics analyses. Microorganisms 8, 2024 (2020).","journal-title":"Microorganisms"},{"key":"551_CR76","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623\u2013628 (2018).","journal-title":"Nature"},{"key":"551_CR77","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.1128\/JB.00714-07","volume":"189","author":"ER Rocha","year":"2007","unstructured":"Rocha, E. R., Tzianabos, A. O. & Smith, C. J. Thioredoxin reductase is essential for thiol\/disulfide redox control and oxidative stress survival of the anaerobe bacteroides fragilis. J. Bacteriol. 189, 8015\u20138023 (2007).","journal-title":"J. Bacteriol."},{"key":"551_CR78","doi-asserted-by":"publisher","first-page":"6863","DOI":"10.1093\/nar\/gkab440","volume":"49","author":"P Szczepanowski","year":"2021","unstructured":"Szczepanowski, P. et al. HP1021 is a redox switch protein identified in Helicobacter pylori. Nucleic Acids Res. 49, 6863\u20136879 (2021).","journal-title":"Nucleic Acids Res."},{"key":"551_CR79","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1128\/jb.178.7.1990-1995.1996","volume":"178","author":"GL Newton","year":"1996","unstructured":"Newton, G. L. et al. Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J. Bacteriol. 178, 1990\u20131995 (1996).","journal-title":"J. Bacteriol."},{"key":"551_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101975","volume":"43","author":"FT Ogata","year":"2021","unstructured":"Ogata, F. T., Branco, V., Vale, F. F. & Coppo, L. Glutaredoxin: discovery, redox defense and much more. Redox Biol. 43, 101975 (2021).","journal-title":"Redox Biol."},{"key":"551_CR81","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1073\/pnas.73.7.2275","volume":"73","author":"A Holmgren","year":"1976","unstructured":"Holmgren, A. Hydrogen donor system for Escherichia coli ribonucleoside-diphosphate reductase dependent upon glutathione. Proc. Natl. Acad. Sci. USA 73, 2275\u20132279 (1976).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"551_CR82","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.91.21.9813","volume":"91","author":"F Aslund","year":"1994","unstructured":"Aslund, F., Ehn, B., Miranda-Vizuete, A., Pueyo, C. & Holmgren, A. Two additional glutaredoxins exist in Escherichia coli: glutaredoxin 3 is a hydrogen donor for ribonucleotide reductase in a thioredoxin\/glutaredoxin 1 double mutant. Proc. Natl. Acad. Sci. USA 91, 9813\u20139817 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"551_CR83","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-genet-102108-134201","volume":"43","author":"Y Meyer","year":"2009","unstructured":"Meyer, Y., Buchanan, B. B., Vignols, F. & Reichheld, J. P. Thioredoxins and glutaredoxins: unifying elements in redox biology. Annu. Rev. Genet. 43, 335\u2013367 (2009).","journal-title":"Annu. Rev. Genet."},{"key":"551_CR84","doi-asserted-by":"crossref","unstructured":"Feng, X. et al. Synergistic activity of colistin combined with auranofin against colistin-resistant gram-negative bacteria. Front. Microbiol. 12, 676414 (2021).","DOI":"10.3389\/fmicb.2021.676414"},{"key":"551_CR85","doi-asserted-by":"crossref","unstructured":"Wensel, C. R., Pluznick, J. L., Salzberg, S. L. & Sears, C. L. Next-generation sequencing: insights to advance clinical investigations of the microbiome. J. Clin. Invest. 132, e154944 (2022).","DOI":"10.1172\/JCI154944"},{"key":"551_CR86","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-0554-6_12","volume":"1151","author":"DE Deatherage","year":"2014","unstructured":"Deatherage, D. E. & Barrick, J. E. Identification of mutations in laboratory evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 1151, 165\u2013188 (2014).","journal-title":"Methods Mol. Biol."},{"key":"551_CR87","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1128\/JB.00272-11","volume":"193","author":"L Saujet","year":"2011","unstructured":"Saujet, L., Monot, M., Dupuy, B., Soutourina, O. & Martin-Verstraete, I. The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile\u25bf. J. Bacteriol. 193, 3186\u20133196 (2011).","journal-title":"J. Bacteriol."},{"key":"551_CR88","doi-asserted-by":"crossref","unstructured":"Soutourina, O. A. et al. Genome-wide identification of regulatory RNAs in the human pathogen Clostridium difficile. PLoS Genet. 9, e1003493 (2013).","DOI":"10.1371\/journal.pgen.1003493"},{"key":"551_CR89","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"551_CR90","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nm.4102","volume":"22","author":"B Lamas","year":"2016","unstructured":"Lamas, B. et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22, 598\u2013605 (2016).","journal-title":"Nat. Med."},{"key":"551_CR91","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"551_CR92","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10\u201312 (2011).","journal-title":"EMBnet J."},{"key":"551_CR93","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: high resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"551_CR94","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"551_CR95","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: Machine Learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res"},{"key":"551_CR96","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).","journal-title":"PLoS ONE"},{"key":"551_CR97","unstructured":"Kassambara, A. rstatix: pipe-friendly framework for basic statistical tests. https:\/\/cran.r-project.org\/web\/packages\/rstatix\/index.html (2023)."},{"key":"551_CR98","doi-asserted-by":"crossref","unstructured":"Wickham, H. et al. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York. https:\/\/ggplot2.tidyverse.org (2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"551_CR99","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"551_CR100","unstructured":"European Committee on Antimicrobial Susceptibility Testing. eucast: Clinical breakpoints and dosing of antibiotics. https:\/\/www.eucast.org\/clinical_breakpoints."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00551-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00551-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00551-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T11:05:47Z","timestamp":1726743947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00551-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1038\/s41522-024-00551-3","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}